{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T02:27:40Z","timestamp":1648866460064},"reference-count":0,"publisher":"Portland Press Ltd.","issue":"s4","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1978,1,1]]},"abstract":"<jats:p>1. Chlorothiazide twice a day plus atenolol, metoprolol, pindolol and propranolol in single daily doses administered to patients with essential hypertension achieved effective control of blood pressure.<\/jats:p>\n               <jats:p>2. Each \u03b2-adrenoreceptor-blocking drug was associated with small, but significant, increases in plasma triglyceride concentrations and suppression of fasting immuno-reactive glucagon concentrations.<\/jats:p>","DOI":"10.1042\/cs055323s","type":"journal-article","created":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T06:34:59Z","timestamp":1438929299000},"page":"323s-324s","update-policy":"http:\/\/dx.doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u03b2-Adrenoreceptor-Blocking Agents and Lipid Metabolism"],"prefix":"10.1042","volume":"55","author":[{"given":"J. D. F.","family":"England","sequence":"first","affiliation":[{"name":"University Department of Medicine, The Royal Melbourne Hospital, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S. P.","family":"Hua","sequence":"additional","affiliation":[{"name":"University Department of Medicine, The Royal Melbourne Hospital, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Shaw","sequence":"additional","affiliation":[{"name":"University Department of Medicine, The Royal Melbourne Hospital, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/portlandpress.com\/clinsci\/article-pdf\/55\/s4\/323s\/740624\/cs055323s.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/portlandpress.com\/clinsci\/article-pdf\/55\/s4\/323s\/740624\/cs055323s.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T04:38:12Z","timestamp":1571978292000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/55\/s4\/323s\/101459\/%CE%B2AdrenoreceptorBlocking-Agents-and-Lipid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1978,1,1]]},"references-count":0,"journal-issue":{"issue":"s4","published-print":{"date-parts":[[1978,1,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs055323s","relation":{},"ISSN":["0144-4107"],"issn-type":[{"value":"0144-4107","type":"print"}],"subject":[],"published":{"date-parts":[[1978,1,1]]}}}